The burden of non‐alcoholic fatty liver disease in Australia: an analysis of <scp>Global Burden of Disease study</scp> from 1990 to 2019-Reference-Cited by-同舟云学术

The burden of non‐alcoholic fatty liver disease in Australia: an analysis of Global Burden of Disease study from 1990 to 2019

Published:2024-07-17 Issue:8 Volume:54 Page:1409-1413
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

George Elena S.¹^ORCID,Sood Surbhi¹,Uddin Riaz¹,Roberts Stuart K.²³^ORCID,Islam Sheikh M. S.¹

Affiliation:

1. Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University Geelong Victoria Australia

2. Department of Gastroenterology and Hepatology Alfred Health Melbourne Victoria Australia

3. Central Clinical School, Monash University Melbourne Victoria Australia

Abstract

AbstractNon‐alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease. Global Burden of Disease (GBD) data from 1990 to 2019 reported a rise in prevalence (9–13%) in Australia, which also ranked third highest for NAFLD prevalence compared to 14 similar countries. As a result of underdiagnosis, NAFLD burden is underestimated by GBD.

Funder

National Heart Foundation of Australia

Bill and Melinda Gates Foundation

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.16457

Reference11 articles.

1. The Social and Economic Cost of Primary Liver Cancer Hepatocellular Carcinoma (HCC) in Australia. Woolloongabba: QLD Liver Foundation; 2021.

2. Nonalcoholic fatty liver disease burden: Australia, 2019–2030

3. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

4. Epidemiology of non-alcoholic fatty liver disease in China

5. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease